Human-assisted Landscape Analysis

Industry-sponsored clinical trials in multiple sclerosis (Oct 2024) – Sample/redacted

  • ClinicalTrials.gov analysis

  • Spec approval to delivery in 5 days

  • Quarterly updates delivered with 1-day turnaround

 

Select Publications

 

Cost-effectiveness analysis (Oncology)
Abbass IM, et al – J Manag Care Spec Pharm 2024 – PubMed
Cost-effectiveness of large-panel next-generation sequencing in guiding first-line treatment decisions for patients with nonsquamous advanced non–small cell lung cancer

Systematic literature review (Influenza)
Blanchet Zumofen MH, Frimpter J, Hansen SA. – PharmacoEconomics 2022 – PubMed
Impact of influenza and influenza‑like illness on work productivity outcomes: A systematic literature review
Cited by The New York Times (Dec 1, 2023)

HRQoL from RCT PROs (Oncology)
Delforge M, et al – Blood Adv – PubMed
Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma

Cost-effectiveness model informed by a SEIR model (Influenza)
Kommandantvold SA, et al – Exp Rev Pharmacoecon Outcomes Res 2024 – PubMed
A cost-effectiveness analysis of reduced viral transmission with baloxavir marboxil versus oseltamivir or no treatment for seasonal and pandemic influenza management in the United Kingdom

Real-world data, registry (Oncology)
Lee HC, et al – Clin Myeloma Lympoma Leuk 2022 – PubMed
Treatment patterns, survival, quality of life, and healthcare resource use among patients with triple-class refractory multiple myeloma in US clinical practice: Findings from the Connect MM Disease Registry

Real-world data, SEER-Medicare linked database (Oncology)
Lee JM, et al – JTO Clin Res Rep 2023 – PubMed
Economic burden of recurrence among resected Medicare patients with early stage NSCLC

Markov model, clinical events and costs (Haemophilia)
Li N, et al – J Med Econ – PubMed
Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic model

Real-world data, Flatiron Health EMR (Oncology)
Saunders A, et al – Leuk Lymphoma – PubMed
Clinical characteristics, treatment patterns, and outcomes among African American and White patients with multiple myeloma in the United States

EMR-based external control arm (Oncology)
Schröder C, et al – JCO Clin Cancer Inform – PubMed
Building external control arms from patient-level electronic health record data to replicate the randomized IMblaze370 control arm in metastatic colorectal cancer

Bayesian network meta-analysis (Oncology)
Vogel A, et al – Liver Cancer – PubMed
Comparative efficacy of atezolizumab plus bevacizumab and other treatment options for patients with unresectable hepatocellular carcinoma: A network meta-analysis

Cost-effectiveness analysis, UK perspective (Oncology)
Yip C-Y, et al – Lung Cancer – PubMed
Cost-effectiveness analysis of adjuvant atezolizumab in stage II-IIIA non-small cell lung cancer expressing >=50% PD-L1: A United Kingdom health care perspective